麻豆传媒

Contact: Lawerence Synett
Office: 412-647-9816
Mobile: 412-302-4127
E-mail: [email protected]

Contact: Arvind Suresh
Office: 412-627-9966
Mobile: 412-509-8207
E-mail: [email protected]

EMBARGOED FOR RELEASE UNTIL 2 P.M. EST, FRIDAY, JUNE 23, 2017 

Earliest Molecular Events Leading to Organ Rejection Identified in Mice 

News — PITTSBURGH, June 23, 2017 – Researchers at the and the have uncovered the first molecular steps that lead to immune system activation and eventual rejection of a transplanted organ. The findings, published today in , may be used someday to create better donor-recipient matches and develop new ways to prevent rejection of transplanted tissues. 

Approximately 50 percent of all transplanted organs are rejected within 10 to 12 years, so there is a great need for better ways to reduce or eliminate organ rejection, explained the study’s co-senior author Fadi Lakkis, M.D., Frank & Athena Sarris Chair in Transplantation Biology and scientific director of Pitt’s (STI). 

“For the first time, we have an insight into the earliest steps that start the rejection response,” Lakkis said. “Interrupting this first recognition of foreign tissues by the innate immune system would disrupt the rejection process at its earliest inception stage and could prevent the transplant from failing.” 

UPMC has been a worldwide leader in organ transplantation for more than 35 years. Throughout its history, the University of Pittsburgh Transplantation Institute, renamed the STI in 1996 in honor of liver transplant pioneer Dr. Thomas E. Starzl, has been creating innovative transplantation strategies. 

“This study is the latest example of the STI’s commitment to improving the lives of patients with organ failure,” Lakkis said. 

The immune system is composed of innate and adaptive branches. The innate immune system is the first to detect foreign cells in the body and is required to activate the adaptive, or acquired, immune system. The mechanisms underlying this second phase of immune activation following organ transplantation are well studied, but the details of how innate immunity contributes to rejection have, until now, remained unknown. 

In the new study, researchers used a classical genetic mapping approach to show that in mice a molecule called SIRP-alpha leads to innate immune system activation and differs between unrelated individuals. When the transplanted tissue SIRP-alpha is different from the host tissue SIRP-alpha, the transplant SIRP-alpha binds to a receptor called CD47 that is located on the recipient’s monocytes, a class of innate immune cells. This binding kicks off a series of cellular events that activate the innate and then eventually the adaptive immune system. 

Like mice, humans also express SIRP-alpha, so sequencing the gene to identify donors and recipients with matched forms of the molecule hopefully will lead to lower organ rejection rates in the future, Lakkis said. 

Blocking the interaction between SIRP-alpha and CD47 in mice prevented the monocyte activation, suggesting that disruption of this coupling could prevent recipient immune system activation. Future studies to examine how the interaction between SIRP-alpha and CD47 leads to monocyte activation could lead to new ways to prevent organ rejection. 

Additional authors on the study were co-senior author Jayne Danska, Ph.D., of the and ; Hehua Dai, M.D., Andrew Friday, Ph.D., Khodor Abou-Daya, M.D., Amanda Williams, M.S., Matthew Nicotra, Ph.D., David Rothstein, M.D., Warren Shlomchik, M.D., Jeffrey Isenberg, Ph.D., and Martin Oberbarnscheidt, M.D., Ph.D., all of Pitt; Steven Mortin-Toth of the Hospital for Sick Children; and Takashi Matozaki, M.D., Ph.D., of Kobe University. 

Funding was provided by grants AI099465 and AI049466, and the . 

# #  # 

About the University of Pittsburgh Schools of the Health Sciences
The University of Pittsburgh Schools of the Health Sciences include the schools of Medicine, Nursing, Dental Medicine, Pharmacy, Health and Rehabilitation Sciences and the Graduate School of Public Health. The schools serve as the academic partner to the UPMC (University of Pittsburgh Medical Center). Together, their combined mission is to train tomorrow’s health care specialists and biomedical scientists, engage in groundbreaking research that will advance understanding of the causes and treatments of disease and participate in the delivery of outstanding patient care. Since 1998, Pitt and its affiliated university faculty have ranked among the top 10 educational institutions in grant support from the National Institutes of Health. For additional information about the Schools of the Health Sciences, please visit .